Quantinno Capital Management’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.63M Buy
48,185
+2,180
+5% +$85.9K ﹤0.01% 2377
2026
Q2
$1.77M Buy
46,005
+5,975
+15% +$182K ﹤0.01% 2076
2026
Q1
$994K Buy
40,030
+25,787
+181% +$668K ﹤0.01% 2169
2025
Q4
$362K Buy
14,243
+2,755
+24% +$61.4K ﹤0.01% 2705
2025
Q3
$185K Buy
+11,488
New +$186K ﹤0.01% 2783

Other funds holding IMVT

Quantinno Capital Management's IMVT Position: Q3 2026 in Review

Quantinno Capital Management increased its Immunovant (IMVT) stake by 4.7% in Q3 2026, buying an estimated $85.9K and bringing the position to 48,185 shares worth $1.63M. The position accounts for ﹤0.01% of the portfolio, ranked #2377.

Quantinno Capital Management first reported a position in IMVT in Q3 2025 and has held it in 5 quarters since. The position peaked at $1.77M in Q2 2026. 232 funds tracked by Wall St. Rank hold IMVT as of Q3 2026.

  • Quantinno Capital Management held 48,185 shares of Immunovant worth $1.63M as of Q3 2026.
  • Quantinno Capital Management bought 2,180 Immunovant shares in Q3 2026, an estimated $85.9K.
  • Immunovant made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #2377 holding.
  • Quantinno Capital Management first reported a position in Immunovant in Q3 2025 and has held it in 5 quarters since.
  • Quantinno Capital Management's Immunovant position peaked at $1.77M in Q2 2026.
  • 232 funds tracked by Wall St. Rank held Immunovant as of Q3 2026.

Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.